Rocket begins patient dosing in phase 1 trial of RP-A501 in Danon disease

Image: Rocket begins patient dosing in phase 1 trial of RP-A501 in monogenic heart failure syndrome. Photo: courtesy of PublicDomainPictures/Pixabay.